Read the latest SARC happenings and access our news archive. to our e-newsletter and receive SARC news and clinical trial updates in your email inbox.

For media inquires and resources, please contact us.


SARC is seeking a part-time Chief Medical Officer (CMO). The CMO (a newly created role for SARC) will work in partnership with the Chief Executive Officer (CEO) and Chief Scientific …

Read more

SARC 2022 Career Development Award

SARC is pleased to announce our 2022 Career Development Award (CDA) funding opportunity. Past graduates (link here) of the SARC CDA program are pursuing productive independent careers at leading institutions …

Read more


Texas Children’s Cancer and Hematology Centers is now open to enrollment in SARC024 (Regorafenib/Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas). SARC024 sites include: • Atrium Health Levine Cancer Institute (Atlanta, GA)• …

Read more
Jonathan Fletcher

SARC appoints Chief Scientific Officer

SARC is pleased to announce that Dr. Jonathan Fletcher has been appointed Chief Scientific Officer. Dr. Fletcher is a lab-based medical and pediatric oncologist at Harvard Medical School, Brigham and Women’s …

Read more
Back to top